Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H29FN4O2 |
| Molecular Weight | 400.4897 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N1CCN(CC1)[C@H]2CCC[C@H](C2)NC(=O)C3=CC4=C(F)C=CC(C)=C4N3
InChI
InChIKey=PGNLXEBQMQHFNK-SJORKVTESA-N
InChI=1S/C22H29FN4O2/c1-14-6-7-19(23)18-13-20(25-21(14)18)22(29)24-16-4-3-5-17(12-16)27-10-8-26(9-11-27)15(2)28/h6-7,13,16-17,25H,3-5,8-12H2,1-2H3,(H,24,29)/t16-,17+/m1/s1
| Molecular Formula | C22H29FN4O2 |
| Molecular Weight | 400.4897 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 13:30:57 GMT 2025
by
admin
on
Wed Apr 02 13:30:57 GMT 2025
|
| Record UNII |
KCY37T9RXU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2411748-50-8
Created by
admin on Wed Apr 02 13:30:57 GMT 2025 , Edited by admin on Wed Apr 02 13:30:57 GMT 2025
|
PRIMARY | |||
|
146395245
Created by
admin on Wed Apr 02 13:30:57 GMT 2025 , Edited by admin on Wed Apr 02 13:30:57 GMT 2025
|
PRIMARY | |||
|
KCY37T9RXU
Created by
admin on Wed Apr 02 13:30:57 GMT 2025 , Edited by admin on Wed Apr 02 13:30:57 GMT 2025
|
PRIMARY | |||
|
C185420
Created by
admin on Wed Apr 02 13:30:57 GMT 2025 , Edited by admin on Wed Apr 02 13:30:57 GMT 2025
|
PRIMARY | |||
|
300000053948
Created by
admin on Wed Apr 02 13:30:57 GMT 2025 , Edited by admin on Wed Apr 02 13:30:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
Inhibitor of the enzymatic activity of histone methyltransferase (HMT) Su(var)3-9, Enhancer-of-zeste, Trithorax domain containing 2 (SETD2), also known as KMT3A. SETD2 catalyzes the S-(5?-Adenosyl)-L-methionine (SAM)-dependent deposition of the third or final methyl group onto the di-methylated state of lysine 36 of histone H3 (H3K36me2) yielding the tri-methylated state of lysine 36 of histone H3 (H3K36me3)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
